<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03111693</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-312</org_study_id>
    <secondary_id>2014-A00975-42</secondary_id>
    <nct_id>NCT03111693</nct_id>
  </id_info>
  <brief_title>CT Evaluation of Cardiovascular Risk Markers in Obese Patients</brief_title>
  <acronym>RisqOScan</acronym>
  <official_title>CT Evaluation of Cardiovascular Risk Markers in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is a chronic metabolic disorder : it leads to coronary heart disease and early
      atherosclerosis.

      Coronary artery calcium measured by CT is known as a robust predictor to predict risk for
      cardiac events in symptomatic and asymptomatic individuals. Furthermore, recent studies show
      that other CT risk factor exists, independent of calcium scoring, such as epicardial fat,
      intrathoracic fat and visceral fat.

      The aim of this prospective study is to evaluate these new cardiovascular risk markers in
      obese patients, using standard dose CT and low dose CT with adaptative statistical iterative
      reconstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective single-center study, obese patients of our clinical nutrition service,
      hospitalized for nutritional assessement, are included.

      All unenhanced coroCT examinations are performed on the same 64-Row CT scanner (discovery CT
      750 HD scanner, GE Healthcare), using prospective ECG-triggerring. The investigation protocol
      began with a standard-dose acquisition followed immediately by a low-dose acquisition,
      recorded over strictly identical segments (identical first and last sections).

      After these two examinations, estimated dose values are less than the diagnostic scan
      reference level for a coroCT.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Epicardial fat evaluation in obese population</measure>
    <time_frame>at day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Calcium scoring evaluation</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">123</enrollment>
  <condition>Epicardial Fat</condition>
  <condition>Obesity</condition>
  <condition>Cardiovascular Risks Markers</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Low Dose Computed Tomography</condition>
  <arm_group>
    <arm_group_label>obese patients</arm_group_label>
    <description>obese patients of our clinical nutrition service, hospitalized for nutrional assessement, are included.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Unenhanced Coro-CT</intervention_name>
    <description>All unenhanced coroCT examinations are performed on the same 64-Row CT scanner (discovery CT 750 HD scanner, GE Helthcare), using prospective ECG-triggerring.</description>
    <arm_group_label>obese patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        obese population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  obesity &gt;30 indicated non enhanced coroCT for calcium scoring.

        Exclusion Criteria:

          -  &lt;18 ans

          -  low Framingham scoring

          -  pregnancy

          -  not providing informed consent

          -  history of cardiovascular disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucie CASSAGNES</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Lucie CASSAGNES</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>April 7, 2017</last_update_submitted>
  <last_update_submitted_qc>April 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epicardial fat</keyword>
  <keyword>Obesity</keyword>
  <keyword>Cardiovascular risks markers</keyword>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Low dose computed tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

